Cannabis Capsule Market Report 2026

The cannabis capsule market size has grown rapidly in recent years. It will grow from $46.98 billion in 2025 to $55.59 billion in 2026 at a compound annual growth rate (CAGR) of 18.3%. The growth in the historic period can be attributed to increasing awareness of medical cannabis benefits, legalization of cannabis in select regions, growing preference for alternative therapies, rising incidence of chronic pain and nausea, advancements in capsule formulation technology.

The cannabis capsule market size is expected to see rapid growth in the next few years. It will grow to $108.48 billion in 2030 at a compound annual growth rate (CAGR) of 18.2%. The growth in the forecast period can be attributed to expansion of legal cannabis markets globally, development of targeted cannabinoid therapies, technological advancements in encapsulation, increased adoption in hospital and retail pharmacies, growing consumer acceptance of wellness-oriented cannabis products. Major trends in the forecast period include personalized cannabinoid therapy, enhanced drug delivery systems, rising medical cannabis acceptance, growth in online pharmacies & e-commerce, regulatory standardization across regions.

The increasing number of neurological disorders is expected to drive the growth of the cannabis capsule market going forward. A neurological disorder is a medical condition that affects the central and peripheral nervous systems, impacting not only the brain but also the nerves of the spinal cord and body. Compounds found in cannabis capsules, such as cannabidiol (CBD), have potential therapeutic effects for neurological disorders and are used to prevent social recognition memory deficits in conditions like Alzheimer’s disease. For instance, in October 2023, according to the World Federation of Neurology, a UK-based association of national neurological societies, more than 40% of the global population currently experiences some form of neurological condition, and this burden is expected to nearly double by 2050. Therefore, the increasing number of neurological disorders is driving the growth of the cannabis capsule market.

Major companies in the cannabis capsule market are focusing on introducing innovative solutions, such as oral cannabis capsules, to gain a competitive advantage. An oral cannabis capsule is a form of cannabis consumption in which compounds, such as oil and decarboxylated flower, are encapsulated in pill form. For instance, in January 2023, Holistic Industries, a US-based organic medical cannabis company, launched CANNACEUTICA in the USA, the first oral cannabis capsule with dosing guidelines specifically designed and studied for people suffering from chronic pain. This first-of-its-kind product serves as an alternative to opioids, with evidence-based dosing instructions. Each bottle includes an Easy Dose Chart to assist users in finding the optimal dose, with a recommended starting dose of 2.5 milligrams of THC (Tetrahydrocannabinol).

In February 2024, Aurora Cannabis Inc., a Canada-based producer of medical and consumer cannabis products, acquired MedReleaf Australia for an undisclosed amount. This acquisition is a strategic move by Aurora Cannabis to expand its market presence, enhance operational performance, and strengthen its leadership position in the global cannabis industry. MedReleaf Australia is an Australia-based manufacturer of medical cannabis products, including cannabis capsules.

Major companies operating in the cannabis capsule market are GW Pharmaceuticals PLC, Trulieve Cannabis Corp., Green Thumb Industries Inc., Tilray Inc., Columbia Care Inc., Aphria Inc., Curaleaf Holdings Inc., Canopy Growth Corporation, Cresco Labs Inc., Aurora Cannabis Inc., Organigram Holdings Inc., Harvest Health & Recreation Inc., Cronos Group Inc., TerrAscend Corp., Vireo Health International Inc., Charlotte's Web Holdings Inc., The Valens Company Inc., Acreage Holdings Inc., Neptune Wellness Solutions Inc., CannTrust Holdings Inc., Valens Company Inc., HEXO Corp., Cann Group Limited, Plus Products Inc., Heritage Cannabis Holdings Corp., PharmaCielo Ltd., MediPharm Labs Corp., Sundial Growers Inc., MedReleaf Corp., Wana Brands.

North America was the largest region in the cannabis capsule market in 2025. The regions covered in the cannabis capsule market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cannabis capsule market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the cannabis capsule market by increasing import and production costs of raw cannabis extracts and packaging materials. The impact is particularly notable on THC-dominant and full-spectrum capsules, affecting North American and European markets where imports are significant. Retail pharmacies and online sales channels face cost pressures, potentially increasing end-user prices. However, tariffs have also encouraged local cultivation and domestic production of cannabinoids, fostering innovation and self-sufficiency within the market.

The cannabis capsule market research report is one of a series of new reports that provides cannabis capsule market statistics, including cannabis capsule industry global market size, regional shares, competitors with a cannabis capsule market share, detailed cannabis capsule market segments, market trends and opportunities, and any further data you may need to thrive in the cannabis capsule industry. This cannabis capsule market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A cannabis capsule, or marijuana pill, is a psychoactive product containing individual cannabinoids, such as THC (tetrahydrocannabinol), CBD (cannabidiol), or the full spectrum of compounds found in the cannabis plant. It is used for medical and recreational purposes, including relief from restlessness, muscle spasms, and chronic pain, as well as reducing nausea and vomiting associated with chemotherapy.

The main types of cannabis capsules include high-tetrahydrocannabinol capsules, tetrahydrocannabinol or cannabinol balance capsules, and high-cannabidiol capsules. High-tetrahydrocannabinol (THC) capsules are oral capsules containing a high concentration of THC, the primary psychoactive component of cannabis. These capsules may include THC-dominant or CBD-dominant formulations and are used by end users such as hospital pharmacies, retail pharmacies, drug stores, and through online sales.

The cannabis capsule market consists of sales of infused oil bases, isolated cannabinoids, and decarboxylated flowers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.